Compare AVY & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVY | BAX |
|---|---|---|
| Founded | 1935 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 13.9B |
| IPO Year | 1994 | 1994 |
| Metric | AVY | BAX |
|---|---|---|
| Price | $168.04 | $22.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 9 |
| Target Price | ★ $205.56 | $21.00 |
| AVG Volume (30 Days) | 942.0K | ★ 4.8M |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.31% | 0.24% |
| EPS Growth | ★ 0.69 | N/A |
| EPS | ★ 4.85 | 0.21 |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $5.70 | $1.96 |
| Revenue Next Year | $3.66 | $2.22 |
| P/E Ratio | ★ $35.28 | $109.62 |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $152.42 | $15.73 |
| 52 Week High | $199.54 | $30.00 |
| Indicator | AVY | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 41.68 | 30.37 |
| Support Level | $166.12 | $21.28 |
| Resistance Level | $186.31 | $23.62 |
| Average True Range (ATR) | 3.80 | 0.78 |
| MACD | -0.74 | -0.32 |
| Stochastic Oscillator | 21.30 | 6.86 |
Avery Dennison Corp provides materials science and digital identification solutions, offering labeling and functional materials, RFID inlays and tags, software connecting physical and digital, and products that enhance packaging and customer experience. Serving industries including retail, apparel, e-commerce, logistics, food, pharmaceuticals, and automotive it operates through two reportable segments: Materials Group, which manufactures and sells pressure-sensitive label materials, graphics, reflective products, performance tapes, and other adhesive solutions, and earns the majority of revenue; and Solutions Group, which provides brand and price tickets, tags, labels with RFID inlays, and related services, supplies, and equipment.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.